Publication

Article Metrics

Citations


Online attention

Regulation of lipid binding underlies the activation mechanism of class IA PI3-kinases

DOI: 10.1038/onc.2011.532 DOI Help
PMID: 22120714 PMID Help

Authors: W-c Hon (MRC Laboratory of Molecular Biology, Cambridge, UK.) , Alex Berndt (MRC Laboratory of Molecular Biology) , R.l. Williams (MRC Laboratory of Molecular Biology, Cambridge, UK.)
Co-authored by industrial partner: No

Type: Journal Paper
Journal: Oncogene

State: Published (Approved)
Published: November 2011
Diamond Proposal Number(s): 6641

Open Access Open Access

Abstract: Somatic missense mutations in PIK3CA, which encodes the p110 alpha catalytic subunit of phosphoinositide 3-kinases, occur frequently in human cancers. Activating mutations spread across multiple domains, some of which are located at inhibitory contact sites formed with the regulatory subunit p85 alpha. PIK3R1, which encodes p85 alpha, also has activating somatic mutations. We find a strong correlation between lipid kinase and lipid-binding activities for both wild-type (WT) and a representative set of oncogenic mutant complexes of p110 alpha/p85 alpha. Lipid binding involves both electrostatic and hydrophobic interactions. Activation caused by a phosphorylated receptor tyrosine kinase (RTK) peptide binding to the p85 alpha N-terminal SH2 domain (nSH2) induces lipid binding. This depends on the polybasic activation loop as well as a conserved hydrophobic motif in the C-terminal region of the kinase domain. The hotspot E545K mutant largely mimics the activated WT p110 alpha. It shows the highest basal activity and lipid binding, and is not significantly activated by an RTK phosphopeptide. Both the hotspot H1047R mutant and rare mutations (C420R, M1043I, H1047L, G1049R and p85 alpha-N564D) also show increased basal kinase activities and lipid binding. However, their activities are further enhanced by an RTK phosphopeptide to levels markedly exceeding that of activated WT p110 alpha. Phosphopeptide binding to p110 beta/p85 alpha and p110 delta/p85 alpha complexes also induces their lipid binding. We present a crystal structure of WT p110 alpha complexed with the p85 alpha inter-SH2 domain and the inhibitor PIK-108. Additional to the ATP-binding pocket, an unexpected, second PIK-108 binding site is observed in the kinase C-lobe. We show a global conformational change in p110 alpha consistent with allosteric regulation of the kinase domain by nSH2. These findings broaden our understanding of the differential biological outputs exhibited by distinct types of mutations regarding growth factor dependence, and suggest a two-tier classification scheme relating p110 alpha and p85 alpha mutations with signalling potential.

Journal Keywords: Amino; Aniline; Animals; Catalytic; Cholesterol; Chromones; Class; Class; Crystallography; X-Ray; Enzyme; Enzyme; Humans; Hydrophobic; Liposomes; Mice; Models; Molecular; Phosphatidylcholines; Phosphatidylethanolamines; Phosphatidylserines; Phosphopeptides; Protein; Quaternary; Protein; Secondary; Sequence Deletion

Subject Areas: Biology and Bio-materials


Instruments: I02-Macromolecular Crystallography , I03-Macromolecular Crystallography

Other Facilities: ESRF